SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 55 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $57,000 | 0.0% | 24,636 | 0.0% | 0.00% | – |
| Q4 2018 | $57,000 | -83.7% | 24,636 | +4.4% | 0.00% | -100.0% |
| Q3 2018 | $350,000 | -2.2% | 23,596 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $358,000 | -17.1% | 23,596 | +2.6% | 0.00% | 0.0% |
| Q1 2018 | $432,000 | +200.0% | 23,000 | +189.8% | 0.00% | – |
| Q4 2017 | $144,000 | -20.9% | 7,937 | -3.2% | 0.00% | – |
| Q3 2017 | $182,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $16,879,000 | 9.55% |
| Partner Investment Management, L.P. | 300,940 | $6,696,000 | 6.35% |
| CLOUGH CAPITAL PARTNERS L P | 751,209 | $16,421,000 | 1.10% |
| Asymmetry Capital Management, L.P. | 41,622 | $926,000 | 1.07% |
| PFM Health Sciences, LP | 1,580,410 | $35,164,000 | 0.69% |
| TimesSquare Capital Management, LLC | 385,200 | $8,571,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 21,189 | $471,000 | 0.04% |
| VICTORY CAPITAL MANAGEMENT INC | 458,340 | $10,198,000 | 0.02% |
| FMR LLC | 3,079,684 | $66,250,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,909 | $1,133,000 | 0.01% |